Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

GW Pharmaceuticals Plc announces proposed public offering of ADSs


Tuesday, 17 Jun 2014 04:06pm EDT 

GW Pharmaceuticals Plc:Says that it and certain of its shareholders intend to sell, subject to market and other conditions, 1.7 mln American Depositary Shares (ADSs) representing ordinary shares of GW on the NASDAQ Global Market in an underwritten U.S. public offering.GW will grant the underwriters 30-day option to purchase up to an additional 255,000 ADSs at the offering price.There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.The price for offering has not yet been determined.Morgan Stanley, BofA Merrill Lynch and Cowen and Company are acting as joint book-running managers for the offering.Piper Jaffray is acting as lead manager. 

Company Quote

385.625
10.625 +2.83%
31 Oct 2014